Stay updated on Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T14:57:46.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The trial status is updated to Terminated with primary results showing no benefit from canakinumab. The previous Active, not recruiting status has been removed.
    Difference
    0.2%
    Check dated 2026-03-04T09:28:00.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The latest version adds a Contacts/Locations section and a Study Status update to the record. These additions improve access to study contact information and the current recruitment status.
    Difference
    0.5%
    Check dated 2026-02-11T10:01:18.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added a site-wide funding/operating status notice and Revision: v3.4.1; removed Revision: v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-04T07:40:00.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    UI improvements include a glossary toggle and color-coded highlights (green for additions, red for deletions, and highlighting of changes) in the study record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-01-28T05:12:50.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    A new site revision label, v3.3.4, was added and the previous revision, v3.3.3, was removed. This represents a routine background update with no changes to trial data or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-01-14T02:43:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.